imiquimod has been researched along with cytidylyl-3'-5'-guanosine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abel, K; Krieg, AM; Lantz, K; McChesney, MB; Miller, CJ; Wang, Y | 1 |
Chen, DP; Lam, CW; Li, EK; Tam, LS; Wong, CK; Wong, PT | 1 |
Bos, JD; Filippov, DV; Konijnenberg, D; Luiten, RM; Meeuwenoord, NJ; Melief, CJ; Picavet, DI; Tjin, EP; van den Boorn, JG; van der Veen, JP | 1 |
3 other study(ies) available for imiquimod and cytidylyl-3'-5'-guanosine
Article | Year |
---|---|
The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.
Topics: Administration, Intravaginal; Aminoquinolines; Animals; Chemokines; Cytokines; Dinucleoside Phosphates; Female; Imiquimod; Macaca mulatta; Oligodeoxyribonucleotides; Simian Acquired Immunodeficiency Syndrome; Vagina | 2005 |
Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
Topics: Adult; Aminoquinolines; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemokines; Dinucleoside Phosphates; Female; Flagellin; Humans; Imiquimod; Immunity, Innate; Interferon Inducers; Interleukins; Leukocytes, Mononuclear; Lipopolysaccharides; Lupus Erythematosus, Systemic; Middle Aged; Monocytes; Peptidoglycan; Poly I-C; RNA; Severity of Illness Index; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; CD8-Positive T-Lymphocytes; Cell Proliferation; Dinucleoside Phosphates; Hydroquinones; Imiquimod; Immunoglobulin G; Immunotherapy; Injections, Subcutaneous; Killer Cells, Natural; Leukocyte Count; Lymphocyte Activation; Lymphocyte Depletion; Melanoma; Mice; Mice, Inbred C57BL; Pigmentation; Skin Neoplasms | 2010 |